Allergic rhinitis (AR) presents a significant global health challenge, affecting a substantial portion of the population and causing considerable illness and disability. Worldwide, its prevalence is concerningly high, reaching up to 40% in more developed nations. Notably, over the past two to three decades, developing countries, including China, have also witnessed a significant rise in AR cases, though the prevalence rates vary across different regions within China. A comprehensive survey conducted over six years among Chinese adults revealed a concerning trend: the standardized prevalence of self-reported AR increased from 11.1% in 2005 to 17.6% in 2011.
This escalating trend has spurred increased research and clinical investigations into the epidemiology, underlying mechanisms, diagnosis, effective management, and associated comorbidities of AR within the Chinese population. The growing body of publications in international peer-reviewed journals over the last two decades has significantly enhanced our understanding of AR as a global health issue. While guidelines for the Diagnosis Chinese methods and treatment of AR in Chinese patients have been established, their availability to the international medical community has been limited due to the lack of English translations. Furthermore, the approaches to diagnosis chinese allergic rhinitis and its treatment have not been fully standardized across China, leading to regional variations in patient care.
In response to these challenges, the Chinese Society of Allergy has developed the present guidelines. These guidelines aim to bridge the accessibility gap for both national and international healthcare professionals involved in managing patients with AR. Developed in alignment with existing international standards, these guidelines provide evidence-based recommendations specifically tailored for the diagnosis chinese landscape of allergic rhinitis and its management within China. By making these guidelines accessible, the Chinese Society of Allergy seeks to contribute to a more standardized and globally informed approach to tackling allergic rhinitis.
